NCT06521931 2026-03-02A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor PatientsChongqing Peg-Bio Biopharm Co., Ltd.Phase 1 Completed24 enrolled